Literature DB >> 3707860

Immunological abnormalities in myelodysplastic syndromes. II. Coexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy.

J A Copplestone, G J Mufti, T J Hamblin, D G Oscier.   

Abstract

We report a series of 20 patients with the myelodysplastic syndrome (MDS) each with a coexistent lymphoid or plasmacytic neoplasm. In none of the patients did chemotherapy play a part in the pathogenesis. The possible reasons for the coincidence of these conditions are discussed. The frequency and variety of associated neoplasms reinforces the idea that in MDS there are genetically unstable progenitor cells liable to clonal differentiation along a variety of pathways given appropriate stimuli.

Entities:  

Mesh:

Year:  1986        PMID: 3707860     DOI: 10.1111/j.1365-2141.1986.tb07505.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  19 in total

1.  Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases.

Authors:  Yataro Yoshida; Shigeru Oguma; Hitoshi Ohno; Yukiharu Nakabo; Tatsuya Katsurada; Masahiro Kawahara; Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2014-04-01       Impact factor: 2.490

2.  Chronic myelomonocytic leukaemia associated with T cell receptor delta gene rearrangement.

Authors:  A B Provan; R V Majer; A G Smith; B Wilkins; E Hodges; J L Smith
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

3.  Unusual association of paroxysmal cold hemoglobinuria as the first sign of disease in myelodysplastic patient.

Authors:  Caterina Stefanizzi; Massimo Breccia; Michelina Santopietro; Serelina Coluzzi; Laura Cannella; Gabriella Girelli; Giuliana Alimena
Journal:  Int J Hematol       Date:  2009-05-26       Impact factor: 2.490

4.  Short or long survival in multiple myeloma. A simple method for determining the prognosis.

Authors:  Judit Várkonyi; Edina Bajzik; Adám Fazakas; Sándor Sipka; István Karádi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

5.  Follicular mucinosis, mycosis fungoides, and acute myeloid leukemia.

Authors:  H W Habboush; N P Lucie; R M Mackie; J Ashworth; M Turbitt
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

6.  Monoclonal gammopathy in chronic myeloproliferative disorders.

Authors:  T Economopoulos; J Economidou; E Papageorgiou; J Dervenoulas; C Christodoulides; V Pappa; D Karakassis; C Terzoglou; S Athanassiadou; G Chalevelakis
Journal:  Blut       Date:  1989-01

7.  Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population.

Authors:  Dragomir Marisavljević; Nada Kraguljac; Zoran Rolović
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

8.  Immunological abnormalities in myelodysplastic syndrome.

Authors:  B Seitanides; A Antonopoulou; A Karabelis
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

9.  Gene expression patterns in myelodyplasia underline the role of apoptosis and differentiation in disease initiation and progression.

Authors:  Merav Bar; Derek Stirewalt; Era Pogosova-Agadjanyan; Vitas Wagner; Ted Gooley; Nissa Abbasi; Ravi Bhatia; H Joachim Deeg; Jerald Radich
Journal:  Transl Oncogenomics       Date:  2008-05-29

Review 10.  Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.

Authors:  D M Layton; G J Mufti
Journal:  Blut       Date:  1986-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.